Jiangsu Nanfang Medical Co., Ltd. (SHA:603880)

China · Delayed Price · Currency is CNY

9.87

+0.15 (1.54%)

Sep 14, 2026, 3:00 PM CST

Jiangsu Nanfang Medical Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	565.28	600.51	602.62	600.1	545.37	527.44
Revenue Growth	-6.84%	-0.35%	0.42%	10.04%	3.40%	-50.82%
Gross Profit	11.21	14.29	-28.91	33.76	67.63	94.52
Operating Income	-81.94	-80.75	-141.05	-90.77	-26.36	-16.01
Net Income	-106.53	-101.71	-190.67	-147.42	-14.65	-22.76
Earnings Per Share	-0.36	-0.35	-0.66	-0.51	-0.05	-0.08
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
China	373.45
Overseas	227.06
Total	600.51

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	57.95	48.35	72.53	118.2	149.04	172.82
Total Debt	433.06	453.84	496.93	469.32	473.5	353.8
Net Cash (Debt)	-375.11	-405.48	-424.41	-351.13	-324.46	-180.98
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.27	-1.40	-1.47	-1.21	-1.11	-0.64

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	16.11	21.19	56	15.51	31.28	-84.25
Capital Expenditures	-2.04	-3.26	-5.11	-66.16	-146.16	-211.75
Free Cash Flow	14.07	17.92	50.89	-50.65	-114.88	-296.01
Free Cash Flow Growth	-83.50%	-64.78%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	1.98%	2.38%	-4.80%	5.63%	12.40%	17.92%
Operating Margin	-14.49%	-13.45%	-23.41%	-15.13%	-4.83%	-3.03%
Pretax Margin	-17.36%	-15.51%	-33.33%	-24.75%	-5.38%	-5.82%
Profit Margin	-18.85%	-16.94%	-31.64%	-24.57%	-2.69%	-4.32%
FCF Margin	2.49%	2.98%	8.44%	-8.44%	-21.07%	-56.12%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
P/FCF Ratio	202.75	100.48	24.71	-	-	-
PS Ratio	5.05	3.00	2.09	2.48	3.33	3.97